Attenuation of PAI-1 synthesis by troglitazone in human arterial smooth muscle cells is affected by the 4g/5g polymorphism in the promoter of the PAI-1 gene

被引：0
|
作者：
Nordt, TK
Eschenfelder, E
Peter, K
Sobel, BE
Bode, C
机构：
[1] Univ Freiburg, Freiburg, Germany
[2] Univ Heidelberg, Heidelberg, Germany
[3] Univ Vermont, Burlington, VT USA
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
217
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [31] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Yildirim, Malik Ejder
    Karakus, Savas
    Kurtulgan, Hande Kucuk
    Kilicgun, Hasan
    Ersan, Serpil
    Bakir, Sevtap
    BIOCHEMICAL GENETICS, 2017, 55 (04) : 314 - 321
  • [32] Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene
    Nordenhem, A
    Wiman, B
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (05): : 453 - 461
  • [33] Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels
    Zietz, B
    Buechler, C
    Drobnik, W
    Herfarth, H
    Schölmerich, J
    Schäffler, MD
    ENDOCRINE RESEARCH, 2004, 30 (03) : 443 - 453
  • [34] 4G/5G polymorphisms of PAI-1 in the metabolic syndrome
    Roncal, C
    Orbe, J
    Rodríguez, JA
    Páramo, JA
    MEDICINA CLINICA, 2006, 126 (06): : 234 - 234
  • [35] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Malik Ejder Yıldırım
    Savas Karakuş
    Hande Küçük Kurtulgan
    Hasan Kılıçgün
    Serpil Erşan
    Sevtap Bakır
    Biochemical Genetics, 2017, 55 : 314 - 321
  • [36] Regular exercise, plasminogen activator inhibitor-1 (PAI-I) activity and the 4G/5G promoter polymorphism in the PAI-1 gene
    Väisänen, SB
    Humphries, SE
    Luong, LA
    Penttilä, I
    Bouchard, C
    Rauramaa, R
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (03) : 1117 - 1120
  • [37] Bilateral pulmonary embolism in twins with PAI-1 4G/5G gene polymorphism: a case reportZwillinge mit bilateraler Pulmonalembolie und PAI-1 4G/5G Genpolymorphismus: Ein Fallbericht
    Andreas Kronbichler
    Peter Oelzner
    Günter Syrbe
    Eric Lopatta
    Gunter Wolf
    Thomas Neumann
    Wiener klinische Wochenschrift, 2014, 126 : 53 - 55
  • [38] PAI-1 promoter 4G/5G polymorphism and fibrinolytic potential in patients with deep vein thrombosis
    Sartori, MT
    Vettore, S
    Radossi, P
    Danesin, C
    Pontarollo, S
    Patrassi, GM
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS398 - PS398
  • [39] The PAI-1 promoter 4G/5G polymorphism does not associate with complications in type 2 diabetes
    Lucchesi, D
    Pucci, L
    Bandinelli, S
    Pilo, M
    Stellini, D
    Giannarelli, R
    del Prato, S
    Penno, G
    DIABETES, 2001, 50 : A177 - A177
  • [40] Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis
    Peres Wingeyer, Silvia
    de Larranaga, Gabriela
    Fontana, Laura
    Cunto, Eleonora
    Nogueras, Cristina
    San Juan, Jorge
    THROMBOSIS RESEARCH, 2010, 125 (04) : 367 - 369
12345